Granulocyte-Macrophage Colony-Stimulating Factor Potentiates Rituximab in Patients With Relapsed Follicular Lymphoma: Results of a Phase II Study
CARTRON, Guillaume, LU, Zhao-Yang, BAUDARD, Marion, KANOUNI, Tarik, ROUILLE, Valérie, QUITTET, Philippe, KLEIN, Bernard, ROSSI, Jean-Francois
Published in Journal of clinical oncology (01.06.2008)
Published in Journal of clinical oncology (01.06.2008)
Get full text
Journal Article
Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial
Guièze, Romain, Ysebaert, Loïc, Roos-Weil, Damien, Fornecker, Luc-Mathieu, Ferrant, Emmanuelle, Molina, Lysiane, Aurran, Thérèse, Clavert, Aline, de Guibert, Sophie, Michallet, Anne-Sophie, Saad, Alain, Drénou, Bernard, Quittet, Philippe, Hivert, Bénédicte, Laribi, Kamel, Gay, Julie, Quinquenel, Anne, Broseus, Julien, Rouille, Valérie, Schwartz, David, Magnin, Benoit, Lazarian, Grégory, Véronèse, Lauren, de Antonio, Marie, Laurent, Camille, Tournilhac, Olivier, Pereira, Bruno, Feugier, Pierre
Published in Nature communications (09.08.2024)
Published in Nature communications (09.08.2024)
Get full text
Journal Article
Increased rituximab exposure does not improve response and outcome of patients with chronic lymphocytic leukemia after fludarabine, cyclophosphamide, rituximab. A French Innovative Leukemia Organization (FILO) study
Cartron, Guillaume, Letestu, Rémi, Dartigeas, Caroline, Tout, Mira, Mahé, Béatrice, Gagez, Anne-Laure, Ferrant, Emmanuelle, Guiu, Boris, Villemagne, Bruno, Letuan, Phan, Aurran, Thérèse, Orsini-Piocelle, Frédérique, Banos, Anne, Feugier, Pierre, Leblond, Véronique, de Guibert, Sophie, Tournilhac, Olivier, Dupuis, Jehan, Delmer, Alain, Rouillé, Valérie, Ternant, David, Leprêtre, Stéphane
Published in Haematologica (Roma) (01.08.2018)
Published in Haematologica (Roma) (01.08.2018)
Get full text
Journal Article
A fixed-duration immunochemotherapy approach in CLL: 5.5-year results from the phase 2 ICLL-07 FILO trial
Michallet, Anne-Sophie, Letestu, Rémi, Le Garff-Tavernier, Magali, Campos, Lydia, Ticchioni, Michel, Dilhuydy, Marie-Sarah, Morisset, Stephane, Rouille, Valérie, Mahé, Béatrice, Laribi, Kamel, Villemagne, Bruno, Ferrant, Emmanuelle, Tournilhac, Olivier, Delmer, Alain, Molina, Lysiane, Leblond, Véronique, Tomowiak, Cécile, de Guibert, Sophie, Orsini-Piocelle, Frederique, Banos, Anne, Carassou, Philippe, Cartron, Guillaume, Fornecker, Luc Mathieu, Ysebaert, Loic, Dartigeas, Caroline, Truchan-Graczyk, Margot, Vilque, Jean-Pierre, Schleinitz, Thérèse Aurran, Cymbalista, Florence, Leprêtre, Stéphane, Lévy, Vincent, Nguyen-Khac, Florence, Feugier, Pierre
Published in Blood advances (08.08.2023)
Published in Blood advances (08.08.2023)
Get full text
Journal Article
Obinutuzumab and ibrutinib induction therapy followed by a minimal residual disease-driven strategy in patients with chronic lymphocytic leukaemia (ICLL07 FILO): a single-arm, multicentre, phase 2 trial
Michallet, Anne-Sophie, Dilhuydy, Marie-Sarah, Subtil, Fabien, Rouille, Valerie, Mahe, Beatrice, Laribi, Kamel, Villemagne, Bruno, Salles, Gilles, Tournilhac, Olivier, Delmer, Alain, Portois, Christelle, Pegourie, Brigitte, Leblond, Veronique, Tomowiak, Cecile, de Guibert, Sophie, Orsini, Frederique, Banos, Anne, Carassou, Philippe, Cartron, Guillaume, Fornecker, Luc Mathieu, Ysebaert, Loic, Dartigeas, Caroline, Truchan Graczyk, Malgorzata, Vilque, Jean P, Aurran, Thérèse, Cymbalista, Florence, Lepretre, Stéphane, Lévy, Vincent, Nguyen-Khac, Florence, Le Garff-Tavernier, Magali, Aanei, Carmen, Ticchioni, Michel, Letestu, Rémi, Feugier, Pierre
Published in The Lancet. Haematology (01.09.2019)
Published in The Lancet. Haematology (01.09.2019)
Get more information
Journal Article
Blinatumomab for Patients with Richter Syndrome: Final Results of the Phase 2 Blinart Trial from the Filo Group
Guieze, Romain, Ysebaert, Loic, Roos-Weil, Damien, Fornecker, Luc-Matthieu, Ferrant, Emmanuelle, Molina, Lysiane, Aurran-Schleinitz, Thérèse, Clavert, Aline, de Guibert, Sophie, Michallet, Anne-Sophie, Saad, Alain, Drenou, Bernard, Quittet, Philippe, Hivert, Benedicte, Laribi, Kamel, Gay, Julie, Broséus, Julien, Rouille, Valérie, Schwartz, David, Pereira, Bruno, Delmer, Alain, Feugier, Pierre
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Blinatumomab after R-CHOP Debulking Therapy for Patients with Richter Transformation: Preliminary Results of the Multicenter Phase 2 Blinart Trial from the Filo Group
Guieze, Romain, Ysebaert, Loic, Molina, Lysiane, Roos-Weil, Damien, Michallet, Anne-Sophie, Hivert, Benedicte, Gay, Julie, Saad, Alain, Fornecker, Luc Mathieu, Broséus, Julien, Rouille, Valérie, Auvray, Laëtitia, Delmer, Alain Jacques, Feugier, Pierre
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
A Fixed-Duration Immunochemotherapy Approach Combined with Ibrutinib in CLL Produces Deep and Sustained MRD Responses: 5.5-Year Results from the Icll-07 Filo Trial
Michallet, Anne-Sophie, Letestu, Rémi, Le Garff-Tavernier, Magali, Aanaei, Carmen, Ticchioni, Michel, Dilhuydy, Marie-Sarah, Morisset, Stephane, Rouille, Valérie, Mahé, Béatrice, Laribi, Kamel, Villemagne, Bruno, Ferrant, Emmanuelle, Tournilhac, Olivier, Delmer, Alain, Portois, Christelle, Molina, Lysiane, Leblond, Véronique, Tomowiak, Cécile, de Guibert, Sophie, Orsini, Frederique, Banos, Anne, Carassou, Philippe, Cartron, Guillaume, Fornecker, Luc Mathieu, Ysebaert, Loic, Dartigeas, Caroline, Truchan, Margot, Vilque, Jean-Pierre, Aurran Schleinitz, Therese, Florence, Cymbalista, Leprêtre, Stéphane, Lévy, Vincent, Nguyen Khac, Florence, Feugier, Pierre
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Blinatumomab for Patients with Richter's Syndrome: A Multicenter Phase 2 Trial from the Filo Group
Guieze, Romain, Ysebaert, Loic, Roos-Weil, Damien, Molina, Lysiane, Fornecker, Luc Mathieu, Aurran, Thérèse, Michallet, Anne-Sophie, Ferrant, Emmanuelle, Clavert, Aline, Saad, Alain, de Guibert, Sophie, Drenou, Bernard, Quittet, Philippe, Hivert, Bénédicte, Laribi, Kamel, Gay, Julie, Broséus, Julien, Rouille, Valérie, Schwartz, David, Pereira, Bruno, Delmer, Alain, Feugier, Pierre
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Preliminary Results of the Filo Phase 2 Trial for Untreated Fit Patients with Intermediate Risk Chronic Lymphocytic Leukemia Comparing Ibrutinib Plus Venetoclax (IV) Versus FCR: Results of the Month 15 MRD Evaluation
Quinquenel, Anne, Letestu, Rémi, Le Garff-Tavernier, Magali, Subtil, Fabien, Aurran-Schleinitz, Therese, Laribi, Kamel, Cymbalista, Florence, Levy, Vincent, Simon, Laurence, Roos-Weil, Damien, Leblond, Véronique, Dilhuydy, Marie-Sarah, Dartigeas, Caroline, Tomowiak, Cecile, Guieze, Romain, Tournilhac, Olivier, Ferrant, Emmanuelle, de Guibert, Sophie, Feugier, Pierre, Merabet, Fatiha, Lepretre, Stephane, Carassou, Philippe, Gay, Julie, Hivert, Bénédicte, Fornecker, Luc Mathieu, Dupuis, Jehan, Molina, Lysiane, Villemagne, Bruno, Cartron, Guillaume, Drenou, Bernard, Mahé, Béatrice, Benbrahim, Omar, Cahu, Xavier, Portois, Christelle, Ysebaert, Loic, Nguyen Khac, Florence, Rouille, Valérie, Delmer, Alain, Michallet, Anne-Sophie
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Retrospective analysis of a cohort of 41 de novo B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study)
Algrin, Caroline, Pérol, Louis, Chapiro, Elise, Baseggio, Lucile, Maloum, Karim, Settegrana, Catherine, Lesesve, Jean-François, Siavellis, Justine, Delmer, Alain, Michallet, Anne-Sophie, Ferrant, Emmanuelle, Feugier, Pierre, Tomowiak, Cécile, Brion, Annie, Ghez, David, Fornecker, Luc-Matthieu, Ivanoff, Sarah, Struski, Stéphanie, Sutton, Laurent, Radford-Weiss, Isabelle, Eclache, Virginie, Lefebvre, Christine, Leblond, Véronique, Nguyen-Khac, Florence, Roos-Weil, Damien
Published in Haematologica (Roma) (01.06.2023)
Published in Haematologica (Roma) (01.06.2023)
Get full text
Journal Article
Preliminary Results of the Filo Phase 2 Trial for Untreated Fit Patients with Intermediate Risk Chronic Lymphocytic Leukemia Comparing Ibrutinib Plus Venetoclax (IV) Versus FCR
Michallet, Anne-Sophie, Quinquenel, Anne, Letestu, Remi, Le Garff-Tavernier, Magali, Subtil, Fabien, Elsensohn, Mad-Helenie, Aurran, Therese, Laribi, Kamel, Cymbalista, Florence, Levy, Vincent, Simon, Laurence, Roos-Weil, Damien, Leblond, Veronique, Dilhuydy, Marie-Sarah, Tomowiak, Cécile, Dartigeas, Caroline, Guieze, Romain, Tournilhac, Olivier, Ferrant, Emmanuelle, de Guibert, Sophie, Feugier, Pierre, Merabet, Fatiha, Leprêtre, Stéphane, Carassou, Philippe, Gay, Julie, Hivert, Bénédicte, Fornecker, Luc Mathieu, Dupuis, Jehan, Molina, Lysiane, Villemagne, Bruno, Cartron, Guillaume, Drenou, Bernard, Mahé, Béatrice, Benbrahim, Omar, Cahu, Xavier, Portois, Christelle, Ysebaert, Loic, Nguyen-Khac, Florence, Rouille, Valérie, Delmer, Alain
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Maintenance of Long-Term Undetectable Minimal Residual Disease after Combination of Ibrutinib with Abbreviated Chemotherapy in the Icll-07 Filo Trial
Michallet, Anne-Sophie, Dilhuydy, Marie-Sarah, Subtil, Fabien, Rouille, Valérie, Mahe, Beatrice, Laribi, Kamel, Villemagne, Bruno, Salles, Gilles A., Tournilhac, Olivier, Delmer, Alain Jacques, Portois, Christelle, Pegourie, Brigitte, Leblond, Veronique, Tomowiak, Cecile, de Guibert, Sophie, Orsini, Frederique, Banos, Anne, Carassou, Philippe, Cartron, Guillaume, Fornecker, Luc Mathieu, Ysebaert, Loic, Dartigeas, Caroline, Truchan, Margot, Vilque, Jean Pierre, Aurran, Thérèse, Cymbalista, Florence, Lepretre, Stephane, Levy, Vincent, Nguyen-Khac, Florence, Le Garff-Tavernier, Magali, Aanaei, Carmen, Ticchioni, Michel, Letestu, Remi, Feugier, Pierre
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
High Rate of Complete Response (CR) with Undetectable Bone Marrow Minimal Residual Disease (MRD) after Chemo-Sparing and MRD-Driven Strategy for Untreated Fit CLL Patients: Final Results of the Icll 07 Filo Trial
Michallet, Anne-Sophie, Dilhuydy, Marie-Sarah, Subtil, Fabien, Rouille, Valérie, Mahe, Beatrice, Laribi, Kamel, Villemagne, Bruno, Salles, Gilles Andre, Tournilhac, Olivier, Delmer, Alain Jacques, Portois, Christelle, Pegourie, Brigitte, Leblond, Véronique, Tomowiak, Cecile, de Guibert, Sophie, Orsini, Frederique, Banos, Anne, Carassou, Philippe, Cartron, Guillaume, Fornecker, Luc Mathieu, Ysebaert, Loic, Dartigeas, Caroline, Truchan, Margot, Aurran, Thérèse, Cymbalista, Florence, Leprêtre, Stéphane, Levy, Vincent, Nguyen-Khac, Florence, Le Garff-Tavernier, Magali, Aanaei, Carmen, Ticchioni, Michel, Letestu, Remi, Feugier, Pierre
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Phase II, Multicenter Trial, Exploring “Chemo-Sparing” Strategy Associating Obinutuzumab+Ibrutinib Followed By a MRD Driven Strategy, in Previously Untreated Symptomatic Medically Fit Chronic Lymphocytic Leukemia Patients (CLL): Preliminary Results of the Induction Phase of the Icll-07 Filo Study
Michallet, Anne-Sophie, Dilhuydy, Marie-Sarah, Subtil, Fabien, Rouille, Valérie, Mahe, Beatrice, Laribi, Kamel, Villemagne, Bruno, Salles, Gilles Andre, Tournilhac, Olivier, Delmer, Alain Jacques, Portois, Christelle, Pegourie, Brigitte, Leblond, Veronique, Tomowiak, Cecile, de Guibert, Sophie, Orsini, Frederique, Banos, Anne, Carassou, Philippe, Cartron, Guillaume, Fornecker, Luc Mathieu, Ysebaert, Loic, Dartigeas, Caroline, Truchan, Margot, Aurran, Thérèse, Cymbalista, Florence, Leprêtre, Stéphane, Levy, Vincent, Nguyen Khac, Florence, Le Garff-Tavernier, Magali, Aanaei, Carmen, Ticchioni, Michel, Letestu, Remi, Feugier, Pierre
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Safety and Long-Term Efficacy of Maintenance Therapy with Alternating Azacytidine (AZA) and Lenalidomide (Len) Cycles in Elderly (≥ 60) Fit Patients (Pts) with Poor Prognosis AML in First Complete Remission (CR) After LIA Induction. A Phase II Multicentric GOELAMS Trial
Hunault, Mathilde, Maillard, Nathalie, Tanguy-Schmidt, Aline, Himberlin, Chantal, Choufi, Bachra, Bonmati, Caroline, Couturier, Marie Anne, Deconinck, Eric, Marolleau, Jean Pierre, Orsini-Piocelle, Frédérique, Delaunay, Jacques, Tavernier, Emmanuelle, Récher, Christian, Lissandre, Severine, Ojeda-Uribe, Mario, Sanhes, Laurence, Sutton, Laurent, Banos, Anne, Lioure, Bruno, Bernard, Marc, Bouscary, Didier, Saad, Alain, Rouille, Valérie, Guardiola, Philippe, Luquet, Isabelle, Bene, Marie C, Dreyfus, Francois, Cahn, Jean-Yves, Pigneux, Arnaud, Ifrah, Norbert
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Maintenance Therapy With Alternating Azacytidine and Lenalidomide Cycles In Elderly (≥ 60) Fit Patients (Pts) With Poor Prognosis AML In First Complete Remission (CR) After Lia Induction. A Phase II Multicentric Goelams Trial
Hunault-Berger, Mathilde, Randriamalala, Edouard, Schmidt-Tanguy, Aline, Himberlin, Chantal, Choufi, Bachra, Bonmati, Caroline, Cahn, Jean Yves, marie-Anne Couturier, MD, Deconinck, Eric, Marolleau, Jean Pierre, orisni-Piocelle, Frederique, Delaunay, Jacques, Tavernier, Emmanuelle, Recher, Christian, Lissandre, Severine, Ojeda-Uribe, Mario, Sanhes, Laurence, Sutton, Laurent, Banos, Anne, Lioure, Bruno, Lamy, Thierry, Bouscary, Didier, Saad, Alain, Rouille, Valérie, Guardiola, Philippe, Luquet, Isabelle, marie-Christine Bene, MD, Dreyfus, Francois, Ifrah, Norbert, Pigneux, Arnaud
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Efficient Vaccination of Follicular Lymphoma (FL) Patients with Multiple Intradermal (ID) and Intravenous (IV) Administrations of Mature Dendritic Cells (DC) Loaded with Tumor Cell Lysate Ex Vivo
Rossi, Jean-Francois, Baudard, Marion, Conge, Anne-Marie, Comte, Frédéric, Costes, Valérie, Veyrunes, Jean-Luc, Quittet, Philippe, Rouillé, Valérie, Barjot, Catherine, Klein, Bernard
Published in Blood (16.11.2005)
Published in Blood (16.11.2005)
Get full text
Journal Article
Prevalence of BTK and PLCG2 mutations in a real-life CLL cohort still on ibrutinib after 3 years: a FILO group study
Quinquenel, Anne, Fornecker, Luc-Matthieu, Letestu, Rémi, Ysebaert, Loïc, Fleury, Carole, Lazarian, Grégory, Dilhuydy, Marie-Sarah, Nollet, Delphine, Guieze, Romain, Feugier, Pierre, Roos-Weil, Damien, Willems, Lise, Michallet, Anne-Sophie, Delmer, Alain, Hormigos, Katia, Levy, Vincent, Cymbalista, Florence, Baran-Marszak, Fanny
Published in Blood (15.08.2019)
Published in Blood (15.08.2019)
Get full text
Journal Article